Four-year maintenance of complete skin clearance with bimekizumab in 10 Spanish patients from the BE RADIANT trial.; Mantenimiento a 4 anos del aclaramiento completo con bimekizumab en 10 pacientes en Espana procedentes del estudio BE RADIANT